We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
201
Meeder Asset Management
Ohio
$1.3M +$167K +1,316 +18%
AB
202
Amalgamated Bank
New York
$1.28M +$62.2K +489 +6%
Public Employees Retirement Association of Colorado
203
Public Employees Retirement Association of Colorado
Colorado
$1.28M +$34.7K +273 +3%
SEI Investments
204
SEI Investments
Pennsylvania
$1.26M +$63.7K +501 +6%
Massachusetts Financial Services
205
Massachusetts Financial Services
Massachusetts
$1.25M +$206K +1,621 +24%
FCM
206
Flinton Capital Management
Pennsylvania
$1.24M +$409K +3,220 +63%
DCM
207
Dupont Capital Management
Delaware
$1.23M – – –
BNP Paribas Asset Management
208
BNP Paribas Asset Management
France
$1.22M +$315K +2,480 +43%
URS
209
Utah Retirement Systems
Utah
$1.18M +$12.7K +100 +1%
Holocene Advisors
210
Holocene Advisors
New York
$1.11M +$954K +7,508 New
RCM
211
Riverhead Capital Management
Delaware
$1.11M +$365K +2,870 +62%
Assenagon Asset Management
212
Assenagon Asset Management
Luxembourg
$1.09M -$239K -1,883 -20%
UBS Group
213
UBS Group
Switzerland
$1.05M -$1.45M -11,369 -62%
VEA
214
Virtus ETF Advisers
New York
$1.05M -$109K -854 -11%
VFA
215
Virtus Fund Advisers
Connecticut
$1.04M +$892K +7,018 New
RGI
216
River Global Investors
United Kingdom
$1.04M – – –
Zurich Cantonal Bank
217
Zurich Cantonal Bank
Switzerland
$1.03M -$148K -1,168 -14%
EMG
218
Ellington Management Group
Connecticut
$1.01M +$864K +6,800 New
PP
219
Paloma Partners
Connecticut
$1M -$836K -6,575 -49%
TAM
220
Tyers Asset Management
Texas
$970K +$322K +2,530 +63%
CGH
221
Crossmark Global Holdings
Texas
$953K +$9.53K +75 +1%
AIM
222
Allen Investment Management
New York
$952K – – –
PCM
223
Piermont Capital Management
Missouri
$941K +$491K +3,860 +154%
COPPSERS
224
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$934K -$3.18K -25 -0.4%
FQ
225
First Quadrant
California
$932K – – –
7 8
9
10 11

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.